O	O	0	5	Nasal	Nasal	B-NP	JJ	B-protein	2	NMOD	B-protein
O	O	6	8	NK	NK	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	8	9	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	10	13	and	and	I-NP	CC	O	8	NMOD	O
O	O	14	15	T	T	I-NP	NN	O	8	NMOD	O
O	O	15	16	-	-	I-NP	HYPH	O	8	NMOD	O
O	O	16	20	cell	cell	I-NP	NN	O	8	NMOD	O
O	O	21	30	lymphomas	lymphoma	I-NP	NNS	O	9	SUB	O
O	O	31	36	share	share	B-VP	VBP	O	0	ROOT	O
O	O	37	40	the	the	B-NP	DT	O	12	NMOD	O
O	O	41	45	same	same	I-NP	JJ	O	12	NMOD	O
O	O	46	50	type	type	I-NP	NN	O	9	OBJ	O
O	O	51	53	of	of	B-PP	IN	O	12	NMOD	O
O	O	54	61	Epstein	Epstein	B-NP	NNP	O	18	NMOD	O
O	O	61	62	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	62	66	Barr	Barr	I-NP	NNP	O	18	NMOD	O
O	O	67	72	virus	virus	I-NP	NN	O	18	NMOD	O
O	O	73	80	latency	latency	I-NP	NN	O	13	PMOD	O
O	O	81	83	as	as	B-PP	IN	O	12	NMOD	O
O	O	84	98	nasopharyngeal	nasopharyngeal	B-NP	JJ	O	21	NMOD	O
O	O	99	108	carcinoma	carcinoma	I-NP	NN	O	26	NMOD	O
O	O	109	112	and	and	I-NP	CC	O	26	NMOD	O
O	O	113	120	Hodgkin	Hodgkin	I-NP	NN	O	26	NMOD	O
O	O	120	121	'	'	I-NP	''	O	26	NMOD	O
O	O	121	122	s	s	I-NP	NN	O	26	NMOD	O
O	O	123	130	disease	disease	I-NP	NN	O	19	PMOD	O
O	O	130	131	.	.	O	.	O	9	P	O

O	O	133	138	Nasal	Nasal	B-NP	JJ	B-cell_type	7	NMOD	B-cell_type
O	O	139	140	T	T	I-NP	NN	I-cell_type	7	NMOD	I-cell_type
O	O	140	141	/	/	B-NP	SYM	I-cell_type	7	NMOD	I-cell_type
O	O	141	143	NK	NK	I-NP	NN	I-cell_type	7	NMOD	I-cell_type
O	O	143	144	-	-	B-NP	HYPH	I-cell_type	7	NMOD	I-cell_type
O	O	144	148	cell	cell	I-NP	NN	I-cell_type	7	NMOD	I-cell_type
O	O	149	158	lymphomas	lymphoma	I-NP	NNS	I-cell_type	8	SUB	I-cell_type
O	O	159	162	can	can	B-VP	MD	O	0	ROOT	O
O	O	163	165	be	be	I-VP	VB	O	8	VC	O
O	O	166	173	further	further	B-ADJP	RBR	O	11	VMOD	O
O	O	174	183	separated	separate	I-ADJP	VBN	O	9	VC	O
O	O	184	188	into	into	B-PP	IN	O	11	VMOD	O
O	O	189	194	those	those	B-NP	DT	O	12	PMOD	O
O	O	195	197	of	of	B-PP	IN	O	13	NMOD	O
O	O	198	205	natural	natural	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	206	212	killer	killer	I-NP	NN	I-cell_type	21	NMOD	I-cell_type
O	O	213	214	(	(	O	(	I-cell_type	19	DEP	I-cell_type
O	O	214	216	NK	NK	B-NP	NN	I-cell_type	19	DEP	I-cell_type
O	O	216	217	)	)	O	)	I-cell_type	21	NMOD	I-cell_type
O	O	218	222	cell	cell	B-NP	NN	I-cell_type	21	NMOD	I-cell_type
O	O	223	230	lineage	lineage	I-NP	NN	I-cell_type	14	PMOD	I-cell_type
O	O	231	233	or	or	B-PP	CC	O	14	PMOD	O
O	O	234	236	of	of	B-PP	IN	O	14	PMOD	O
O	O	237	238	T	T	B-NP	NN	B-cell_type	27	NMOD	B-cell_type
O	O	238	239	-	-	I-NP	HYPH	I-cell_type	27	NMOD	I-cell_type
O	O	239	243	cell	cell	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	244	251	lineage	lineage	I-NP	NN	I-cell_type	23	PMOD	I-cell_type
O	O	251	252	,	,	O	,	O	13	P	O
O	O	253	257	with	with	B-PP	IN	O	13	NMOD	O
O	O	258	269	differences	difference	B-NP	NNS	O	29	PMOD	O
O	O	270	272	in	in	B-PP	IN	O	30	NMOD	O
O	O	273	281	cellular	cellular	B-NP	JJ	O	33	NMOD	O
O	O	282	291	phenotype	phenotype	I-NP	NN	O	38	NMOD	O
O	O	291	292	,	,	O	,	O	38	P	O
T12	B-Entity	293	294	T	T	B-NP	NN	B-protein	38	NMOD	B-protein
T12	I-Entity	294	295	-	-	I-NP	HYPH	I-protein	38	NMOD	I-protein
T12	I-Entity	295	299	cell	cell	I-NP	NN	I-protein	38	NMOD	I-protein
T12	I-Entity	300	308	receptor	receptor	I-NP	NN	I-protein	43	NMOD	I-protein
T12	I-Entity	309	310	(	(	O	(	O	41	DEP	O
T12	I-Entity	310	313	TcR	TcR	B-NP	NN	O	41	DEP	O
T12	I-Entity	313	314	)	)	O	)	O	38	NMOD	O
T12	I-Entity	315	319	gene	gene	B-NP	NN	O	43	NMOD	O
O	O	320	333	rearrangement	rearrangement	I-NP	NN	O	47	NMOD	O
O	O	334	337	and	and	O	CC	O	47	NMOD	O
O	O	338	341	TcR	TcR	B-NP	NN	B-protein	47	NMOD	B-protein
O	O	342	352	transcript	transcript	I-NP	NN	O	47	NMOD	O
O	O	353	363	expression	expression	I-NP	NN	O	31	PMOD	O
O	O	363	364	.	.	O	.	O	8	P	O

O	O	365	369	Both	Both	O	CC	O	8	NMOD	O
O	O	370	372	NK	NK	B-NP	NN	O	8	NMOD	O
O	O	372	373	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	374	377	and	and	I-NP	CC	O	8	NMOD	O
O	O	378	379	T	T	I-NP	NN	O	8	NMOD	O
O	O	379	380	-	-	I-NP	HYPH	O	8	NMOD	O
O	O	380	384	cell	cell	I-NP	NN	O	8	NMOD	O
O	O	385	393	subtypes	subtype	I-NP	NNS	O	9	SUB	O
O	O	394	397	are	be	B-VP	VBP	O	0	ROOT	O
O	O	398	405	closely	closely	I-VP	RB	O	9	VMOD	O
O	O	406	416	associated	associate	I-VP	VBN	O	9	VC	O
O	O	417	421	with	with	B-PP	IN	O	11	VMOD	O
O	O	422	429	Epstein	Epstein	B-NP	NNP	O	16	NMOD	O
O	O	429	430	-	-	I-NP	HYPH	O	16	NMOD	O
O	O	430	434	Barr	Barr	I-NP	NNP	O	16	NMOD	O
O	O	435	440	virus	virus	I-NP	NN	O	12	PMOD	O
O	O	441	442	(	(	O	(	O	19	DEP	O
O	O	442	445	EBV	EBV	B-NP	NN	O	19	DEP	O
O	O	445	446	)	)	O	)	O	16	NMOD	O
O	O	446	447	.	.	O	.	O	9	P	O

O	O	448	450	In	In	B-PP	IN	O	8	VMOD	O
O	O	451	455	this	this	B-NP	DT	O	3	NMOD	O
O	O	456	461	study	study	I-NP	NN	O	1	PMOD	O
O	O	461	462	,	,	O	,	O	8	P	O
T13	B-Entity	463	466	EBV	EBV	B-NP	NN	B-DNA	7	NMOD	B-DNA
T13	I-Entity	467	471	gene	gene	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	472	482	expression	expression	I-NP	NN	O	8	SUB	O
O	O	483	486	was	be	B-VP	VBD	O	0	ROOT	O
O	O	487	497	determined	determine	I-VP	VBN	O	8	VC	O
O	O	498	500	in	in	B-PP	IN	O	9	VMOD	O
O	O	501	503	23	23	B-NP	CD	O	12	NMOD	O
O	O	504	509	cases	case	I-NP	NNS	O	10	PMOD	O
O	O	510	512	of	of	B-PP	IN	O	12	NMOD	O
O	O	513	518	nasal	nasal	B-NP	JJ	O	15	NMOD	O
O	O	519	527	lymphoma	lymphoma	I-NP	NN	O	13	PMOD	O
O	O	528	529	(	(	O	(	O	18	DEP	O
O	O	529	531	NL	NL	B-NP	NN	B-protein	18	DEP	B-protein
O	O	531	532	)	)	O	)	O	15	NMOD	O
O	O	533	535	by	by	B-PP	IN	O	9	VMOD	O
O	O	536	538	in	in	B-NP	FW	O	21	AMOD	O
O	O	539	543	situ	situ	I-NP	FW	O	22	NMOD	O
O	O	544	557	hybridisation	hybridisation	I-NP	NN	O	28	NMOD	O
O	O	558	559	(	(	O	(	O	25	DEP	O
O	O	559	562	ISH	ISH	B-NP	NN	O	25	DEP	O
O	O	562	563	)	)	O	)	O	22	NMOD	O
O	O	563	564	,	,	O	,	O	28	P	O
O	O	565	572	reverse	reverse	B-NP	JJ	B-protein	28	NMOD	B-protein
O	O	573	586	transcriptase	transcriptase	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	586	587	-	-	B-NP	HYPH	O	32	NMOD	O
O	O	587	597	polymerase	polymerase	I-NP	NN	O	32	NMOD	O
O	O	598	603	chain	chain	I-NP	NN	O	32	NMOD	O
O	O	604	612	reaction	reaction	I-NP	NN	O	39	NMOD	O
O	O	613	614	(	(	O	(	O	37	DEP	O
O	O	614	616	RT	RT	B-NP	NN	O	36	NMOD	O
O	O	616	617	-	-	B-NP	HYPH	O	36	P	O
O	O	617	620	PCR	PCR	I-NP	NN	O	37	DEP	O
O	O	620	621	)	)	O	)	O	32	NMOD	O
O	O	622	625	and	and	O	CC	O	39	NMOD	O
O	O	626	646	immunohistochemistry	immunohistochemistry	B-NP	NN	O	19	PMOD	O
O	O	647	648	(	(	O	(	O	42	DEP	O
O	O	648	650	IH	IH	B-NP	NN	O	42	DEP	O
O	O	650	651	)	)	O	)	O	39	NMOD	O
O	O	651	652	.	.	O	.	O	8	P	O

O	O	653	655	Of	Of	B-PP	IN	O	7	VMOD	O
O	O	656	659	the	the	B-NP	DT	O	4	NMOD	O
O	O	660	662	23	23	I-NP	CD	O	4	NMOD	O
O	O	663	668	cases	case	I-NP	NNS	O	1	PMOD	O
O	O	668	669	,	,	O	,	O	7	P	O
O	O	670	672	19	19	B-NP	CD	O	7	SUB	O
O	O	673	677	were	be	B-VP	VBD	O	0	ROOT	O
O	O	678	688	classified	classify	I-VP	VBN	O	7	VC	O
O	O	689	691	as	as	B-PP	IN	O	8	VMOD	O
O	O	692	694	NK	NK	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	694	695	-	-	I-NP	HYPH	I-cell_type	12	NMOD	I-cell_type
O	O	695	699	cell	cell	I-NP	NN	I-cell_type	9	PMOD	I-cell_type
O	O	700	703	and	and	O	CC	O	8	VMOD	O
O	O	704	705	4	4	B-NP	CD	O	8	VMOD	O
O	O	706	708	as	as	B-SBAR	IN	O	8	VMOD	O
O	O	709	710	T	T	B-NP	NN	O	19	NMOD	O
O	O	710	711	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	711	715	cell	cell	I-NP	NN	O	19	NMOD	O
O	O	716	723	tumours	tumour	I-NP	NNS	O	15	PMOD	O
O	O	723	724	.	.	O	.	O	7	P	O

O	O	725	728	ISH	ISH	B-NP	NN	O	11	SUB	O
O	O	729	732	for	for	B-PP	IN	O	1	NMOD	O
O	O	733	736	EBV	EBV	B-NP	NN	B-DNA	10	NMOD	B-DNA
O	O	736	737	-	-	O	HYPH	I-DNA	10	NMOD	I-DNA
O	O	737	744	encoded	encode	B-VP	VBN	I-DNA	10	NMOD	I-DNA
O	O	745	750	small	small	B-NP	JJ	I-DNA	7	NMOD	I-DNA
O	O	751	754	non	non	I-NP	AFX	I-DNA	10	NMOD	I-DNA
O	O	754	755	-	-	I-NP	HYPH	B-RNA	10	NMOD	B-RNA
O	O	755	769	polyadenylated	polyadenylate	I-NP	VBN	I-RNA	10	NMOD	I-RNA
O	O	770	774	RNAs	RNA	I-NP	NNS	I-RNA	2	PMOD	I-RNA
O	O	775	781	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	782	786	that	that	B-SBAR	IN	O	11	VMOD	O
O	O	787	790	all	all	B-NP	DT	O	14	NMOD	O
O	O	791	796	cases	case	I-NP	NNS	O	21	SUB	O
O	O	796	797	,	,	O	,	O	21	P	O
O	O	798	805	whether	whether	B-SBAR	IN	O	21	VMOD	O
O	O	806	808	NK	NK	B-NP	NN	O	19	NMOD	O
O	O	809	811	or	or	I-NP	CC	O	19	NMOD	O
O	O	812	813	T	T	I-NP	NN	O	16	DEP	O
O	O	813	814	,	,	O	,	O	21	P	O
O	O	815	824	harboured	harbour	B-VP	VBD	O	12	SBAR	O
O	O	825	828	EBV	EBV	B-NP	NN	O	21	OBJ	O
O	O	829	831	in	in	B-PP	IN	O	21	VMOD	O
O	O	832	841	virtually	virtually	B-NP	RB	O	25	AMOD	O
O	O	842	845	all	all	I-NP	DT	O	27	NMOD	O
O	O	846	852	tumour	tumour	I-NP	NN	B-cell_type	27	NMOD	B-cell_type
O	O	853	858	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	858	859	.	.	O	.	O	11	P	O

O	O	860	862	RT	RT	B-NP	NN	O	3	NMOD	O
O	O	862	863	-	-	I-NP	HYPH	O	3	NMOD	O
O	O	863	866	PCR	PCR	I-NP	NN	O	4	SUB	O
O	O	867	879	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	880	884	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	885	887	NL	NL	B-NP	NNP	B-cell_type	10	SUB	B-cell_type
O	O	888	890	of	of	B-PP	IN	O	6	NMOD	O
O	O	891	895	both	both	B-NP	DT	O	9	NMOD	O
O	O	896	904	subtypes	subtype	I-NP	NNS	O	7	PMOD	O
O	O	905	914	expressed	express	B-VP	VBD	O	5	SBAR	O
T1	B-Protein	915	920	EBNAI	EBNAI	B-NP	NN	B-protein	10	OBJ	B-protein
O	O	921	923	of	of	B-PP	IN	O	11	NMOD	O
O	O	924	927	the	the	B-NP	DT	O	16	NMOD	O
O	O	928	931	QUK	QUK	I-NP	NN	O	16	NMOD	O
O	O	932	938	splice	splice	I-NP	NN	O	16	NMOD	O
O	O	939	946	pattern	pattern	I-NP	NN	O	12	PMOD	O
O	O	946	947	,	,	O	,	O	4	P	O
O	O	948	951	the	the	B-NP	DT	O	21	NMOD	O
O	O	952	958	latent	latent	I-NP	JJ	B-protein	21	NMOD	B-protein
O	O	959	967	membrane	membrane	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	968	976	proteins	protein	I-NP	NNS	I-protein	31	NMOD	I-protein
O	O	976	977	,	,	O	,	O	31	P	O
T2	B-Protein	978	982	LMP1	LMP1	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	983	986	and	and	O	CC	I-protein	25	NMOD	I-protein
T3	B-Protein	987	988	2	2	B-NP	CD	I-protein	31	NMOD	I-protein
O	O	989	992	and	and	O	CC	O	31	NMOD	O
O	O	993	996	the	the	B-NP	DT	O	31	NMOD	O
O	O	997	1002	BamHI	BamHI	I-NP	NN	B-RNA	31	NMOD	B-RNA
O	O	1003	1004	A	A	I-NP	NN	I-RNA	31	NMOD	I-RNA
O	O	1005	1014	rightward	rightward	I-NP	JJ	I-RNA	31	NMOD	I-RNA
O	O	1015	1026	transcripts	transcript	I-NP	NNS	I-RNA	4	VMOD	I-RNA
O	O	1027	1029	in	in	B-PP	IN	O	31	NMOD	O
O	O	1030	1033	the	the	B-NP	DT	O	34	NMOD	O
O	O	1034	1041	absence	absence	I-NP	NN	O	32	PMOD	O
O	O	1042	1044	of	of	B-PP	IN	O	34	NMOD	O
T4	B-Protein	1045	1050	EBNA2	EBNA2	B-NP	NN	B-RNA	37	NMOD	B-RNA
O	O	1051	1056	mRNAs	mRNA	I-NP	NNS	I-RNA	35	PMOD	I-RNA
O	O	1056	1057	,	,	O	,	O	31	P	O
O	O	1058	1068	compatible	compatible	B-ADJP	JJ	O	31	NMOD	O
O	O	1069	1073	with	with	B-PP	IN	O	39	AMOD	O
O	O	1074	1077	the	the	B-NP	DT	O	45	NMOD	O
O	O	1078	1085	latency	latency	I-NP	NN	O	45	NMOD	O
O	O	1086	1090	type	type	I-NP	NN	O	45	NMOD	O
O	O	1091	1093	II	II	I-NP	CD	O	45	NMOD	O
O	O	1094	1101	pattern	pattern	I-NP	NN	O	40	PMOD	O
O	O	1101	1102	.	.	O	.	O	4	P	O

O	O	1103	1105	In	In	B-PP	IN	O	11	VMOD	O
O	O	1106	1114	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	1114	1115	,	,	O	,	O	11	P	O
O	O	1116	1124	analysis	analysis	B-NP	NN	O	11	SUB	O
O	O	1125	1127	of	of	B-PP	IN	O	4	NMOD	O
O	O	1128	1131	EBV	EBV	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	1132	1139	protein	protein	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	1140	1150	expression	expression	I-NP	NN	O	5	PMOD	O
O	O	1151	1153	by	by	B-PP	IN	O	8	NMOD	O
O	O	1154	1156	IH	IH	B-NP	NN	O	9	PMOD	O
O	O	1157	1165	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	1166	1167	a	a	B-NP	DT	O	14	NMOD	O
O	O	1168	1181	heterogeneous	heterogeneous	I-NP	JJ	O	14	NMOD	O
O	O	1182	1189	pattern	pattern	I-NP	NN	O	11	OBJ	O
O	O	1190	1192	of	of	B-PP	IN	O	14	NMOD	O
T14	B-Entity	1193	1196	EBV	EBV	B-NP	NN	B-DNA	18	NMOD	B-DNA
T14	I-Entity	1197	1201	gene	gene	I-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	1202	1212	expression	expression	I-NP	NN	O	15	PMOD	O
O	O	1213	1215	at	at	B-PP	IN	O	18	NMOD	O
O	O	1216	1219	the	the	B-NP	DT	O	24	NMOD	O
O	O	1220	1226	single	single	I-NP	JJ	O	24	NMOD	O
O	O	1226	1227	-	-	I-NP	HYPH	O	24	NMOD	O
O	O	1227	1231	cell	cell	I-NP	NN	O	24	NMOD	O
O	O	1232	1237	level	level	I-NP	NN	O	19	PMOD	O
O	O	1238	1248	consisting	consist	B-VP	VBG	O	24	NMOD	O
O	O	1249	1251	of	of	B-PP	IN	O	25	VMOD	O
O	O	1252	1256	both	both	O	CC	O	34	NMOD	O
T5	B-Protein	1257	1261	LMP1	LMP1	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	1261	1262	+	+	B-NP	SYM	O	34	NMOD	O
O	O	1263	1266	and	and	O	CC	O	34	NMOD	O
T6	B-Protein	1267	1271	LMP1	LMP1	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	1271	1272	-	-	I-NP	HYPH	O	34	NMOD	O
O	O	1273	1279	tumour	tumour	I-NP	NN	B-cell_type	34	NMOD	B-cell_type
O	O	1280	1285	cells	cell	I-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	1285	1286	,	,	O	,	O	11	P	O
O	O	1287	1297	suggesting	suggest	B-VP	VBG	O	11	VMOD	O
O	O	1298	1299	a	a	B-NP	DT	O	38	NMOD	O
O	O	1300	1307	mixture	mixture	I-NP	NN	O	36	OBJ	O
O	O	1308	1310	of	of	B-PP	IN	O	38	NMOD	O
O	O	1311	1318	latency	latency	B-NP	NN	O	39	PMOD	O
O	O	1319	1320	I	I	I-NP	CD	O	43	NMOD	O
O	O	1321	1324	and	and	I-NP	CC	O	43	NMOD	O
O	O	1325	1327	II	II	I-NP	CD	O	40	NMOD	O
O	O	1327	1328	.	.	O	.	O	11	P	O

O	O	1329	1337	Although	Although	B-SBAR	IN	O	30	VMOD	O
O	O	1338	1339	2	2	B-NP	CD	B-RNA	5	NMOD	B-RNA
O	O	1340	1345	early	early	I-NP	JJ	I-RNA	5	NMOD	I-RNA
O	O	1346	1351	lytic	lytic	I-NP	JJ	I-RNA	5	NMOD	I-RNA
O	O	1352	1363	transcripts	transcript	I-NP	NNS	I-RNA	9	NMOD	I-RNA
O	O	1363	1364	,	,	O	,	O	9	P	O
T7	B-Protein	1365	1370	BZLF1	BZLF1	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	1371	1374	and	and	O	CC	O	9	NMOD	O
T8	B-Protein	1375	1380	BHRF1	BHRF1	B-NP	NN	B-protein	11	SUB	B-protein
O	O	1380	1381	,	,	O	,	O	9	P	O
O	O	1382	1386	were	be	B-VP	VBD	O	1	SBAR	O
O	O	1387	1391	also	also	I-VP	RB	O	11	VMOD	O
O	O	1392	1400	detected	detect	I-VP	VBN	O	11	VC	O
O	O	1401	1403	in	in	B-PP	IN	O	13	VMOD	O
O	O	1404	1406	13	13	B-NP	CD	O	17	AMOD	O
O	O	1407	1410	and	and	I-NP	CC	O	17	AMOD	O
O	O	1411	1413	10	10	I-NP	CD	O	18	NMOD	O
O	O	1414	1419	cases	case	I-NP	NNS	O	14	PMOD	O
O	O	1419	1420	,	,	O	,	O	11	P	O
O	O	1421	1433	respectively	respectively	B-ADVP	RB	O	11	VMOD	O
O	O	1433	1434	,	,	O	,	O	30	P	O
O	O	1435	1438	the	the	B-NP	DT	O	23	NMOD	O
O	O	1439	1443	lack	lack	I-NP	NN	O	30	SUB	O
O	O	1444	1446	of	of	B-PP	IN	O	23	NMOD	O
T9	B-Protein	1447	1452	ZEBRA	ZEBRA	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	1453	1461	staining	staining	I-NP	NN	O	24	PMOD	O
O	O	1462	1464	in	in	B-PP	IN	O	23	NMOD	O
O	O	1465	1468	any	any	B-NP	DT	O	29	NMOD	O
O	O	1469	1473	case	case	I-NP	NN	O	27	PMOD	O
O	O	1474	1483	indicates	indicate	B-VP	VBZ	O	0	ROOT	O
O	O	1484	1488	that	that	B-SBAR	IN	O	30	VMOD	O
O	O	1489	1494	these	these	B-NP	DT	O	34	NMOD	O
O	O	1495	1500	lytic	lytic	I-NP	JJ	B-RNA	34	NMOD	B-RNA
O	O	1501	1512	transcripts	transcript	I-NP	NNS	I-RNA	35	SUB	I-RNA
O	O	1513	1516	are	be	B-VP	VBP	O	31	SBAR	O
O	O	1517	1521	most	most	I-VP	RBS	O	37	AMOD	O
O	O	1522	1528	likely	likely	I-VP	RB	O	38	VMOD	O
O	O	1529	1538	expressed	express	I-VP	VBN	O	35	VC	O
O	O	1539	1541	by	by	B-PP	IN	O	38	VMOD	O
O	O	1542	1546	rare	rare	B-NP	JJ	B-cell_type	41	NMOD	B-cell_type
O	O	1547	1552	cells	cell	I-NP	NNS	I-cell_type	39	PMOD	I-cell_type
O	O	1553	1555	in	in	B-PP	IN	O	41	NMOD	O
O	O	1556	1559	the	the	B-NP	DT	O	44	NMOD	O
O	O	1560	1568	biopsies	biopsy	I-NP	NNS	O	42	PMOD	O
O	O	1569	1577	entering	enter	B-VP	VBG	O	44	NMOD	O
O	O	1578	1583	lytic	lytic	B-NP	JJ	O	47	NMOD	O
O	O	1584	1589	cycle	cycle	I-NP	NN	O	45	OBJ	O
O	O	1589	1590	.	.	O	.	O	30	P	O

O	O	1591	1594	The	The	B-NP	DT	O	4	NMOD	O
O	O	1595	1600	viral	viral	I-NP	JJ	O	4	NMOD	O
O	O	1601	1616	transcriptional	transcriptional	I-NP	JJ	O	4	NMOD	O
O	O	1617	1624	pattern	pattern	I-NP	NN	O	16	SUB	O
O	O	1625	1632	similar	similar	B-ADJP	JJ	O	4	NMOD	O
O	O	1633	1635	to	to	B-PP	TO	O	5	AMOD	O
O	O	1636	1640	that	that	B-NP	DT	O	6	PMOD	O
O	O	1641	1643	of	of	B-PP	IN	O	7	NMOD	O
O	O	1644	1658	nasopharyngeal	nasopharyngeal	B-NP	JJ	O	10	NMOD	O
O	O	1659	1668	carcinoma	carcinoma	I-NP	NN	O	15	NMOD	O
O	O	1669	1672	and	and	I-NP	CC	O	15	NMOD	O
O	O	1673	1680	Hodgkin	Hodgkin	I-NP	NN	O	15	NMOD	O
O	O	1680	1681	'	'	I-NP	''	O	15	NMOD	O
O	O	1681	1682	s	s	I-NP	NN	O	15	NMOD	O
O	O	1683	1690	disease	disease	I-NP	NN	O	8	PMOD	O
O	O	1691	1699	suggests	suggest	B-VP	VBZ	O	0	ROOT	O
O	O	1700	1704	that	that	B-SBAR	IN	O	16	VMOD	O
O	O	1705	1708	EBV	EBV	B-NP	NN	O	19	SUB	O
O	O	1709	1712	can	can	B-VP	MD	O	17	SBAR	O
O	O	1713	1720	exploit	exploit	I-VP	VB	O	19	VC	O
O	O	1721	1727	common	common	B-NP	JJ	O	23	NMOD	O
O	O	1728	1738	regulatory	regulatory	I-NP	JJ	O	23	NMOD	O
O	O	1739	1749	mechanisms	mechanism	I-NP	NNS	O	20	OBJ	O
O	O	1750	1753	for	for	B-PP	IN	O	23	NMOD	O
O	O	1754	1758	gene	gene	B-NP	NN	O	26	NMOD	O
O	O	1759	1772	transcription	transcription	I-NP	NN	O	24	PMOD	O
O	O	1773	1775	in	in	B-PP	IN	O	26	NMOD	O
O	O	1776	1783	diverse	diverse	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	1784	1788	host	host	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	1789	1793	cell	cell	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	1794	1799	types	type	I-NP	NNS	I-cell_type	27	PMOD	I-cell_type
O	O	1799	1800	.	.	O	.	O	16	P	O

O	O	1801	1805	Down	Down	B-ADVP	RB	O	15	VMOD	O
O	O	1805	1806	-	-	O	HYPH	O	15	P	O
O	O	1806	1816	regulation	regulation	B-NP	NN	O	15	SUB	O
O	O	1817	1819	of	of	B-PP	IN	O	3	NMOD	O
O	O	1820	1831	immunogenic	immunogenic	B-NP	JJ	B-protein	6	NMOD	B-protein
O	O	1832	1840	proteins	protein	I-NP	NNS	I-protein	4	PMOD	I-protein
O	O	1841	1842	(	(	O	(	O	11	DEP	O
T10	B-Protein	1842	1847	EBNA2	EBNA2	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	1847	1848	-	-	B-NP	HYPH	O	10	P	O
T11	B-Protein	1848	1853	EBNA6	EBNA6	I-NP	NN	B-protein	11	DEP	B-protein
O	O	1853	1854	)	)	O	)	O	6	NMOD	O
O	O	1855	1857	in	in	B-PP	IN	O	3	NMOD	O
O	O	1858	1863	nasal	nasal	B-NP	JJ	O	14	NMOD	O
O	O	1864	1872	lymphoma	lymphoma	I-NP	NN	O	12	PMOD	O
O	O	1873	1876	may	may	B-VP	MD	O	0	ROOT	O
O	O	1877	1883	enable	enable	I-VP	VB	O	15	VC	O
O	O	1884	1890	tumour	tumour	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	1891	1896	cells	cell	I-NP	NNS	I-cell_type	20	SUB	I-cell_type
O	O	1897	1899	to	to	B-VP	TO	O	20	VMOD	O
O	O	1900	1905	evade	evade	I-VP	VB	O	16	VMOD	O
O	O	1906	1910	host	host	B-NP	NN	O	26	NMOD	O
O	O	1911	1920	cytotoxic	cytotoxic	I-NP	JJ	O	26	NMOD	O
O	O	1921	1922	T	T	I-NP	NN	O	26	NMOD	O
O	O	1922	1923	-	-	I-NP	HYPH	O	26	NMOD	O
O	O	1923	1927	cell	cell	I-NP	NN	O	26	NMOD	O
O	O	1928	1940	surveillance	surveillance	I-NP	NN	O	20	OBJ	O
O	O	1940	1941	.	.	O	.	O	15	P	O
